5-35709082-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024867.4(SPEF2):​c.2800G>C​(p.Ala934Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.776 in 1,613,346 control chromosomes in the GnomAD database, including 487,090 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43326 hom., cov: 31)
Exomes 𝑓: 0.78 ( 443764 hom. )

Consequence

SPEF2
NM_024867.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.47

Publications

25 publications found
Variant links:
Genes affected
SPEF2 (HGNC:26293): (sperm flagellar 2) Involved in sperm axoneme assembly. Located in sperm flagellum. Implicated in spermatogenic failure 43. [provided by Alliance of Genome Resources, Apr 2022]
SPEF2 Gene-Disease associations (from GenCC):
  • spermatogenic failure 43
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.2953827E-5).
BP6
Variant 5-35709082-G-C is Benign according to our data. Variant chr5-35709082-G-C is described in ClinVar as [Benign]. Clinvar id is 403479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.788 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPEF2NM_024867.4 linkc.2800G>C p.Ala934Pro missense_variant Exon 19 of 37 ENST00000356031.8 NP_079143.3 Q9C093-1A0A140VKD0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPEF2ENST00000356031.8 linkc.2800G>C p.Ala934Pro missense_variant Exon 19 of 37 1 NM_024867.4 ENSP00000348314.3 Q9C093-1

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114257
AN:
151964
Hom.:
43311
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.664
Gnomad AMI
AF:
0.828
Gnomad AMR
AF:
0.774
Gnomad ASJ
AF:
0.787
Gnomad EAS
AF:
0.780
Gnomad SAS
AF:
0.686
Gnomad FIN
AF:
0.782
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.794
Gnomad OTH
AF:
0.770
GnomAD2 exomes
AF:
0.755
AC:
187832
AN:
248832
AF XY:
0.758
show subpopulations
Gnomad AFR exome
AF:
0.660
Gnomad AMR exome
AF:
0.681
Gnomad ASJ exome
AF:
0.804
Gnomad EAS exome
AF:
0.776
Gnomad FIN exome
AF:
0.771
Gnomad NFE exome
AF:
0.794
Gnomad OTH exome
AF:
0.772
GnomAD4 exome
AF:
0.778
AC:
1137128
AN:
1461264
Hom.:
443764
Cov.:
50
AF XY:
0.777
AC XY:
564449
AN XY:
726882
show subpopulations
African (AFR)
AF:
0.663
AC:
22183
AN:
33460
American (AMR)
AF:
0.692
AC:
30897
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.801
AC:
20940
AN:
26134
East Asian (EAS)
AF:
0.799
AC:
31717
AN:
39684
South Asian (SAS)
AF:
0.699
AC:
60207
AN:
86086
European-Finnish (FIN)
AF:
0.769
AC:
41014
AN:
53344
Middle Eastern (MID)
AF:
0.824
AC:
4748
AN:
5764
European-Non Finnish (NFE)
AF:
0.790
AC:
878607
AN:
1111732
Other (OTH)
AF:
0.775
AC:
46815
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
12854
25708
38563
51417
64271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20634
41268
61902
82536
103170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.752
AC:
114321
AN:
152082
Hom.:
43326
Cov.:
31
AF XY:
0.752
AC XY:
55934
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.664
AC:
27552
AN:
41474
American (AMR)
AF:
0.774
AC:
11832
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.787
AC:
2731
AN:
3468
East Asian (EAS)
AF:
0.780
AC:
4028
AN:
5164
South Asian (SAS)
AF:
0.685
AC:
3298
AN:
4814
European-Finnish (FIN)
AF:
0.782
AC:
8264
AN:
10562
Middle Eastern (MID)
AF:
0.830
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
0.794
AC:
53989
AN:
67988
Other (OTH)
AF:
0.771
AC:
1628
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1442
2885
4327
5770
7212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.786
Hom.:
15329
Bravo
AF:
0.744
TwinsUK
AF:
0.791
AC:
2932
ALSPAC
AF:
0.790
AC:
3045
ESP6500AA
AF:
0.672
AC:
2496
ESP6500EA
AF:
0.794
AC:
6506
ExAC
AF:
0.755
AC:
91235
Asia WGS
AF:
0.713
AC:
2479
AN:
3476
EpiCase
AF:
0.800
EpiControl
AF:
0.800

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Spermatogenic failure 43 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.030
DANN
Benign
0.48
DEOGEN2
Benign
0.0016
.;T;T;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0022
N
LIST_S2
Benign
0.32
T;T;T;T
MetaRNN
Benign
0.000023
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-1.4
.;.;N;.
PhyloP100
-2.5
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.23
N;.;N;N
REVEL
Benign
0.020
Sift
Benign
0.54
T;.;T;T
Sift4G
Benign
0.43
T;.;T;T
Polyphen
0.0
B;.;B;B
Vest4
0.043
MPC
0.034
ClinPred
0.00030
T
GERP RS
-2.1
Varity_R
0.044
gMVP
0.17
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13170390; hg19: chr5-35709184; COSMIC: COSV61545824; COSMIC: COSV61545824; API